Although introduced for the treatment of maculopathies, photodynamic therapy (PDT) is now largely used in some eye cancers treatment. The selective tissue damage with PDT is achieved by sequestration of the photosensitizer in the target tissue and focal activation of the photosensitizer by low energy directed light. In this way, it is possible to achieve the destruction of the tumor tissue by safeguarding the surrounding healthy structures. Our study describes the clinical uses and efficacy of photodynamic therapy in ocular oncology.
Blasi, M. A., Pagliara, M. M., Lanza, A., Sammarco, M. G., Caputo, C. G., Grimaldi, G., Scupola, A., Photodynamic Therapy in Ocular Oncology, <<BIOMEDICINES>>, 2018; 6 (1): N/A-N/A. [doi:10.3390/biomedicines6010017] [http://hdl.handle.net/10807/115544]
Photodynamic Therapy in Ocular Oncology
Blasi, Maria Antonietta;Pagliara, Monica Maria;Lanza, Angela;Sammarco, Maria Grazia;Caputo, Carmela Grazia;Grimaldi, Gabriela;Scupola, Andrea
2018
Abstract
Although introduced for the treatment of maculopathies, photodynamic therapy (PDT) is now largely used in some eye cancers treatment. The selective tissue damage with PDT is achieved by sequestration of the photosensitizer in the target tissue and focal activation of the photosensitizer by low energy directed light. In this way, it is possible to achieve the destruction of the tumor tissue by safeguarding the surrounding healthy structures. Our study describes the clinical uses and efficacy of photodynamic therapy in ocular oncology.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
